ArticleScience (New York, N.Y.)2022

GPNMB confers risk for Parkinson's disease through interaction with α-synuclein.

Maria E Diaz-Ortiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.